Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 10—October 2026
Research
Meta-analysis of Asymptomatic Monkeypox Virus Prevalence in Nonendemic Regions, 2022–2024
Kelsey J. MacCuish, Robert Snyder, Kelly A. Johnson, Edwin Chojolan, Awa Keinde, Kathleen Jacobson, and Kayla Saadeh
Table 2
Odds ratios and 95% CIs for meta-regression analysis of asymptomatic monkeypox virus detections in nonendemic regions, by geographic region and study design
| Meta-regression variable | Odds ratio (95% CI) |
|---|---|
| Asia vs. North America | 0.45 (0.02–10.03) |
| Europe vs. North America | 1.70 (0.29–10.05) |
| Mixed cohort vs. cross-sectional | 0.06 (0.00–3.94) |
| Prospective cohort vs. cross-sectional | 0.17 (0.02–1.20) |
| Retrospective cohort vs. cross-sectional | 0.24 (0.03–1.83) |
Page created: August 05, 2026
Page updated: September 16, 2026
Page reviewed: September 16, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.